Angela Grant Sells 397 Shares of Palomar (NASDAQ:PLMR) Stock

Palomar Holdings, Inc. (NASDAQ:PLMR) insider Angela Grant sold 397 shares of the firm’s stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $122.04, for a total value of $48,449.88. Following the transaction, the insider owned 5,939 shares of the company’s stock, valued at $724,795.56. This trade represents a 6.27% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Palomar Trading Up 0.5%

PLMR stock traded up $0.63 during trading on Monday, hitting $124.22. The company had a trading volume of 240,836 shares, compared to its average volume of 180,129. The stock has a market cap of $3.29 billion, a PE ratio of 19.38 and a beta of 0.44. The business has a 50-day moving average of $127.67 and a 200-day moving average of $123.57. Palomar Holdings, Inc. has a one year low of $104.47 and a one year high of $175.85.

Palomar (NASDAQ:PLMR) last issued its quarterly earnings results on Thursday, November 6th. The company reported $2.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.56 by $0.45. Palomar had a net margin of 22.59% and a return on equity of 21.93%. The firm had revenue of $244.66 million for the quarter, compared to the consensus estimate of $207.98 million. During the same quarter in the previous year, the company earned $1.23 EPS. Research analysts forecast that Palomar Holdings, Inc. will post 5.99 EPS for the current year.

More Palomar News

Here are the key news stories impacting Palomar this week:

• Positive Sentiment: Palomar closed the acquisition of The Gray Casualty & Surety Company, expanding its surety capabilities and product mix — a strategic tuck?in that can add premium, diversify risk exposure and support growth in specialty lines. BCP Completes Sale of The Gray Casualty & Surety Company
• Neutral Sentiment: Palomar will report Q4 and full?year 2025 results after the close on Feb 11, 2026, with a conference call Feb 12 — an event that typically drives short?term volume and volatility as investors update estimates and listen for management commentary on reserve development, underwriting margin, and growth. Earnings Release & Conference Call
• Negative Sentiment: Multiple insiders (including the CEO, President, CFO and other senior executives) sold shares on Jan. 29 and Jan. 31, reducing positions by low-single-digit percentages in many cases. Heavy insider selling can signal liquidity taking or tax/comp planning, but it may concern some investors about insider confidence or timing ahead of earnings. Representative coverage of recent insider sales is here. CEO Sells Stock (Example)

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in PLMR. Allworth Financial LP grew its stake in Palomar by 1,970.0% in the second quarter. Allworth Financial LP now owns 207 shares of the company’s stock valued at $32,000 after acquiring an additional 197 shares during the period. Salomon & Ludwin LLC acquired a new position in shares of Palomar during the third quarter worth approximately $25,000. Richardson Financial Services Inc. lifted its holdings in shares of Palomar by 210.0% in the 3rd quarter. Richardson Financial Services Inc. now owns 217 shares of the company’s stock worth $25,000 after purchasing an additional 147 shares in the last quarter. Geneos Wealth Management Inc. acquired a new stake in Palomar in the 4th quarter valued at $32,000. Finally, Hollencrest Capital Management increased its stake in Palomar by 56.5% during the 2nd quarter. Hollencrest Capital Management now owns 313 shares of the company’s stock valued at $48,000 after purchasing an additional 113 shares in the last quarter. 90.25% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts have weighed in on the company. Weiss Ratings upgraded Palomar from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, January 14th. JPMorgan Chase & Co. upped their target price on Palomar from $145.00 to $155.00 and gave the company an “overweight” rating in a research report on Wednesday, January 7th. Wall Street Zen raised Palomar from a “hold” rating to a “buy” rating in a research note on Saturday, January 10th. Finally, Keefe, Bruyette & Woods boosted their price target on Palomar from $170.00 to $171.00 and gave the company an “outperform” rating in a research note on Tuesday, January 6th. Six research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, Palomar presently has an average rating of “Moderate Buy” and a consensus target price of $159.50.

Palomar Company Profile

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.